EXHIBIT 99.1 Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, "Aligos"), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today reported recent business progress and financial results for the third quarter 2024. "This quarter we reached a key milestone when we announce ...